232 related articles for article (PubMed ID: 6442059)
1. [HLA antigens and side effects of gold and D-penicillamine in chronic polyarthritis].
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb N
Wien Klin Wochenschr Suppl; 1984; 156():51-2. PubMed ID: 6442059
[No Abstract] [Full Text] [Related]
2. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
[TBL] [Abstract][Full Text] [Related]
4. HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
Pachoula-Papasteriades C; Boki K; Varla-Leftherioti M; Kappos-Rigatou I; Fostiropoulos G; Economidou J
Dis Markers; 1986 Jun; 4(1-2):35-41. PubMed ID: 3133153
[TBL] [Abstract][Full Text] [Related]
5. Histocompatibility antigens in adult obliterative bronchiolitis with or without rheumatoid arthritis.
Sweatman MC; Markwick JR; Charles PJ; Jones SE; Prior JM; Maini RN; Turner-Warwick ME
Dis Markers; 1986 Jun; 4(1-2):19-26. PubMed ID: 3133152
[TBL] [Abstract][Full Text] [Related]
6. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
[No Abstract] [Full Text] [Related]
7. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
8. Penicillamine in rheumatic diseases: a prospective study of tolerance and efficacy.
Munthe E; Kåss E
J Rheumatol Suppl; 1981; 7():107-11. PubMed ID: 6785435
[TBL] [Abstract][Full Text] [Related]
9. Is the mechanism of action during treatment of rheumatoid arthritis with penicillamine and gold thiomalate the same?
Jellum E; Aaseth J; Munthe E
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):136-9. PubMed ID: 122761
[No Abstract] [Full Text] [Related]
10. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Dahlqvist SR; Ström H; Bjelle A; Möller E
Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
[TBL] [Abstract][Full Text] [Related]
11. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
Leonard PA; Bienz SR; Clegg DO; Ward JR
J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
[TBL] [Abstract][Full Text] [Related]
12. Gold vs D-penicillamine double blind study and followup.
Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
[TBL] [Abstract][Full Text] [Related]
13. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens.
Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK
J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.
Speerstra F; Reekers P; van de Putte LB; Vandenbroucke JP; Rasker JJ; de Rooij DJ
J Rheumatol; 1983 Dec; 10(6):948-53. PubMed ID: 6420562
[TBL] [Abstract][Full Text] [Related]
15. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
Schlumpf U; Bussmann HU; Jerusalem F
Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
[TBL] [Abstract][Full Text] [Related]
16. Precipitating autoantibody to a ubiquitous tissue antigen: association with rheumatoid arthritis treated with sodium aurothiomalate or d-penicillamine.
Palosuo T; Kajander A; von Essen R; Milgrom F
Clin Immunol Immunopathol; 1978 Jul; 10(3):355-64. PubMed ID: 97039
[No Abstract] [Full Text] [Related]
17. Genetic markers in rheumatoid arthritis relationship to toxicity from D-penicillamine.
Stockman A; Zilko PJ; Major GA; Tait BD; Property DN; Mathews JD; Hannah MC; McCluskey J; Muirden KD
J Rheumatol; 1986 Apr; 13(2):269-73. PubMed ID: 3459889
[TBL] [Abstract][Full Text] [Related]
18. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
Redda A; Anastassiades T
Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
[TBL] [Abstract][Full Text] [Related]
19. Ankylosing spondylitis and rheumatoid arthritis in a patient with Paget's disease. Differential effects of indomethacin, D-penicillamine, or gold sodium thiomalate in the respective arthritides.
Alarcón-Segovia D; Martínez-Cordero E
Arch Intern Med; 1985 Oct; 145(10):1915-7. PubMed ID: 3929708
[TBL] [Abstract][Full Text] [Related]
20. Adverse reactions to D-penicillamine after gold toxicity.
Dodd MJ; Griffiths ID; Thompson M
Br Med J; 1980 Jun; 280(6230):1498-500. PubMed ID: 6770953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]